Study tests recombinant irisin as a novel broiler feed additive

Version 2 — Full analysis

A newly published study in Veterinary Sciences explores an unusual candidate for broiler nutrition: recombinant irisin, a hormone-like myokine better known from mammalian metabolism research than poultry feed formulation. Based on the article abstract, the study tested whether dietary recombinant irisin could influence growth performance, serum antioxidant and immune indices, and cecal microbiota in male white-feathered broilers, framing the molecule as a potential tool to improve resilience under intensive production conditions. (mdpi.com)

That fits a larger industry and research trend. In the post-antibiotic-growth-promoter era, poultry nutrition research has increasingly turned toward additives that can support feed efficiency, oxidative balance, immune function, and intestinal health at the same time. Recent broiler studies have looked at compounds ranging from tryptophan and rutin to lysozyme, probiotics, phytobiotics, and engineered protein products, often using the same package of endpoints seen here: body weight gain, feed conversion, serum antioxidant markers, inflammatory or immunoglobulin measures, and cecal microbiota sequencing. (pubmed.ncbi.nlm.nih.gov)

What makes this paper different is the additive itself. Irisin is produced by cleavage of FNDC5 and has been studied primarily in mammals for roles in energy metabolism, muscle biology, oxidative regulation, and inflammation. Web research turned up very little evidence that irisin has already become an established poultry feed ingredient, which suggests this broiler paper is testing a relatively novel concept rather than building on an active commercial category. One recent poultry paper did report that irisin overexpression reduced hepatic lipid accumulation and inflammatory and oxidative stress markers in chickens, offering some biologic rationale for interest in the molecule in avian systems. (mdpi.com)

The source abstract indicates the investigators were focused on whether recombinant irisin could improve not just growth, but also physiologic resilience. That’s notable because broiler feeding trials increasingly recognize that performance outcomes alone can miss meaningful changes in stress biology and gut ecology. The cecal microbiota, in particular, is now treated as a relevant production variable because of its links to nutrient metabolism, pathogen resistance, and immune signaling. Research in broilers has shown that dietary interventions can shift microbial composition alongside antioxidant and immune readouts, but those effects don’t always translate cleanly into better field performance. (pubmed.ncbi.nlm.nih.gov)

I didn’t find a press release or substantial outside expert commentary specifically on this irisin paper, which in itself is worth noting. Most of the available context comes from adjacent poultry nutrition literature and from broader irisin biology reviews, not from poultry industry groups or regulators weighing in on immediate application. That lack of reaction suggests the study is being received, at least for now, as an exploratory academic finding rather than a market-moving development. (mdpi.com)

Why it matters: For veterinary professionals advising poultry operations, this study is best read as an early indicator of where feed additive science is going. The industry continues to look for non-antibiotic tools that can support performance while also improving oxidative and immune status, especially in high-density systems where stress, inflammation, and gut instability can undermine outcomes. If recombinant irisin meaningfully improves feed conversion, antioxidant markers, and microbial balance without adverse effects, it could eventually widen the menu of precision nutrition tools. But there are still major practical questions: how recombinant irisin would be manufactured at scale, whether it remains stable in feed, what dose range is effective, whether benefits persist across breeds and environments, and what regulatory pathway would apply in feed markets. Those are the issues veterinarians, nutritionists, and integrators would need answered before considering real-world use. (pmc.ncbi.nlm.nih.gov)

What to watch: The next step is the full data readout: dose levels, magnitude of any feed-conversion or weight-gain effect, the specific immune and antioxidant markers that changed, and which bacterial taxa shifted in the cecum. After that, the important milestones would be replication in larger and more commercial broiler populations, safety and residue assessment if relevant, and any sign that recombinant irisin is moving from bench science toward feed additive development or regulatory review. (pubmed.ncbi.nlm.nih.gov)